Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Inflammatory Bowel Diseases

  Free Subscription


31.08.2026

3 Aliment Pharmacol Ther
1 Am J Gastroenterol
2 Clin Gastroenterol Hepatol
6 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gut
3 Inflamm Bowel Dis
3 J Crohns Colitis
1 Scand J Gastroenterol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. KOPPELMAN LJM, Loveikyte R, van der Meulen-de Jong AE
    Letter: External Validation of Hepcidin Thresholds for Predicting Response to Iron Therapy in Active Inflammatory Bowel Disease. Authors' Reply.
    Aliment Pharmacol Ther. 2026 Aug 26. doi: 10.1111/apt.70927.
    PubMed        

  2. MURAMOTO Y, Kuwada T, Shiokawa M
    Editorial: Anti-Integrin alphavbeta6 Autoantibodies for Distinguishing Ulcerative Colitis From Crohn's Disease.
    Aliment Pharmacol Ther. 2026 Aug 23. doi: 10.1111/apt.70947.
    PubMed        

  3. SAWARD G, Heerasing N
    Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough?
    Aliment Pharmacol Ther. 2026 Aug 23. doi: 10.1111/apt.70943.
    PubMed        


    Am J Gastroenterol

  4. CONTIJOCH E, Moses J
    Early Use of Anti-Tumor Necrosis Factor Therapy for Penetrating Complications in Children With Crohn's Disease: Multicenter Insight to a Challenging Clinical Problem.
    Am J Gastroenterol. 2026 Aug 27. doi: 10.14309/ajg.0000000000004154.
    PubMed        


    Clin Gastroenterol Hepatol

  5. RIBALDONE DG, Tribocco E, Scaldaferri F, Murgiano M, et al
    Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.
    Clin Gastroenterol Hepatol. 2026 Aug 27:S1542-3565(26)00637.
    PubMed         Abstract available

  6. FORSS A, Axelrad J, Soderling J, Marild K, et al
    Serious infections in patients with inflammatory bowel disease and corticosteroids: A propensity score-matched study.
    Clin Gastroenterol Hepatol. 2026 Aug 28:S1542-3565(26)00642.
    PubMed         Abstract available


    Dig Dis Sci

  7. MIKHAIL I, Odah T, Hashash JG, Farraye J, et al
    Association Between Inflammatory Bowel Disease in Women and the Fertility Marker Anti-Mullerian Hormone.
    Dig Dis Sci. 2026 Aug 21. doi: 10.1007/s10620-026-10191.
    PubMed         Abstract available

  8. HU X, Chen J, Zhou Y, Ji X, et al
    n-3 Polyunsaturated Fatty Acids Improve DSS-Induced Acute Colitis in Mice via Intestinal Barrier Fortification and Gut Microbiome Modulation.
    Dig Dis Sci. 2026;71:4252-4269.
    PubMed         Abstract available

  9. CLARKE K, Pelton M, Barnes EL, Liu JJ, et al
    IBD Care Across Diverse Patient Populations: Changing the Narrative.
    Dig Dis Sci. 2026;71:3844-3849.
    PubMed         Abstract available

  10. MAYER L, Frech M, Ekowa N, Boone DL, et al
    A Proposed Standardized Scoring Equation for Murine Models of Colitis.
    Dig Dis Sci. 2026;71:3448-3457.
    PubMed         Abstract available

  11. WANG J, Luo A, Yao Y, Liu A, et al
    cGAS-STING Modulates the NF-kappaB Pathway to Influence the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.
    Dig Dis Sci. 2026 Aug 24. doi: 10.1007/s10620-026-10183.
    PubMed         Abstract available

  12. MOGHE R, Klein J, Choden T
    Holding the Line: Navigating Upadacitinib-Induced Neutropenia in Refractory Ulcerative Colitis.
    Dig Dis Sci. 2026 Aug 25. doi: 10.1007/s10620-026-10176.
    PubMed        


    Eur J Gastroenterol Hepatol

  13. KARIM A, Alam T, Masood M, Kumari K, et al
    Beyond tissue drug concentrations: additional considerations in anti-tumor necrosis factor penetration among patients with perianal fistulizing Crohn's disease.
    Eur J Gastroenterol Hepatol. 2026;38:1239.
    PubMed        


    Gut

  14. CHEN R, Kim HJ, Bushra M, Phi Dang C, et al
    Childhood exposure to a sibling with Crohn's disease alters gut microbiome and Crohn's disease susceptibility.
    Gut. 2026 Aug 25:gutjnl-2026-339257. doi: 10.1136/gutjnl-2026-339257.
    PubMed         Abstract available


    Inflamm Bowel Dis

  15. SHAHUB S, Lin KC, Choi NK, Garcia NM, et al
    Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease.
    Inflamm Bowel Dis. 2026 Aug 28:izag173. doi: 10.1093.
    PubMed         Abstract available

  16. QURAISHI MN, Jairath V, Al-Bawardy B
    Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.
    Inflamm Bowel Dis. 2026 Aug 27:izag172. doi: 10.1093.
    PubMed         Abstract available

  17. DIAZ-DIAZ LM, Estremera-Rodriguez L, Rojas-Correa M, Quintana MDC, et al
    Diet quality, gut microbiome, and inflammatory signatures in Puerto Rican adults with Crohn disease: a multidimensional analysis.
    Inflamm Bowel Dis. 2026 Aug 26:izag161. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  18. GUO A, Sigvardsson I, Imberg H, Lerchova T, et al
    Modifiable lifestyle factors in early life and inflammatory bowel disease risk in two birth cohorts.
    J Crohns Colitis. 2026;20:jjag114.
    PubMed         Abstract available

  19. FRASCATANI R, Serra MA, Iannucci A, Colella M, et al
    BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype.
    J Crohns Colitis. 2026;20:jjag128.
    PubMed         Abstract available

  20. KENNEDY JM, De Silva AN, Morales PS, Poveda Turrado CG, et al
    2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial.
    J Crohns Colitis. 2026;20:jjag120.
    PubMed         Abstract available


    Scand J Gastroenterol

  21. BORKOVSKY T, Cohen NA, Shoam O, Bannon L, et al
    Factors associated with mesalamine refractory ulcerative proctitis requiring advanced medical treatments.
    Scand J Gastroenterol. 2026;61:956-963.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum